NXL
Nexalin Technology, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$2.36
+0.43%Price chart
Sep 18Sep 23Sep 28Oct 1Oct 6Oct 9Oct 14Oct 19
Key dataOct 19, 2026
Open$2.40
From 52W high−78.45%
Volume57430.00
Market cap$2.47M
P/E (TTM)—
P/S (TTM)11.4x
Div yield—
Key dataOct 19, 2026
Open
$2.40
From 52W high
−78.45%
Volume
57430.00
Market cap
$2.47M
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
−0.2x
P/E (TTM)
—
RSI (14)
31.5
MomentumView details →
1D Return
+0.43%
YTD Return
+288.89%
SummaryUpdated Jun 1, 2026
Nexalin Technology, Inc. (NASDAQ:NXL) is a medical device company founded in 2021 and headquartered in Houston, Texas. The company went public in September 2022 and specializes in developing neurostimulation products for treating mental health conditions. Nexalin focuses on non-invasive, drug-free therapeutic devices that use proprietary frequency-based waveforms to stimulate brain structures associated with various mental health disorders.
Similar companies
Latest newsMore news →
Nexalin Technology, Inc. said it regained compliance with NASDAQ, INC.’s minimum bid price requirement and that a NASDAQ, INC. Hearings Panel granted its request for continued listing.12d agoNexalin Technology signed an exclusive distribution agreement appointing INOVANEXA MEDICAL TECHNOLOGIES S.A. to distribute its Nexalin Sync neurostimulation device in Brazil, Argentina, Chile, Uruguay, Paraguay, Ecuador and Venezuela.18d ago